|        |  |  |
|--------|--|--|
|   |
|   |

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549__________________

FORM 8-KCURRENT REPORTPursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): August 1, 2024THE CLOROX COMPANY(Exact name of registrant as specified in its charter)__________________Delaware1-0715131-0595760(State or other jurisdiction of(Commission File Number)(I.R.S. Employerincorporation)Identification No.)1221 Broadway, Oakland, California94612-1888(Address of principal executive offices) (Zip code)(510) 271-7000(Registrant's telephone number, including area code)Not applicable(Former name or former address, if changed since last report)Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:[ ]Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)  [ ]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  [ ]Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  [ ]Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))Securities registered pursuant to Section 12(b) of the Act:Title of each classTradingSymbol(s)Name of each exchange on which registeredCommon Stock - $1.00 par valueCLXNew York Stock ExchangeIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).Emerging growth company     ☐If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐  1Item 2.02 Results of Operations and Financial ConditionOn August 1, 2024, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2024. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.Item 7.01 Regulation FD DisclosureAttached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information. The Clorox Company additionally announced in the press release that it has entered into a definitive agreement to divest its Better Health Vitamins, Minerals and Supplements business.Item 9.01 Financial Statements and Exhibits(d) ExhibitsSee the Exhibit Index below.EXHIBIT INDEXExhibit     Description99.1Press Release dated August 1, 2024 of The Clorox Company99.2Supplemental information regarding financial results104Cover Page Interactive Data File (embedded within the Inline XBRL document)2SIGNATURESPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.THE CLOROX COMPANY  Date: August 1, 2024By:/s/ Angela HiltAngela HiltExecutive Vice President – Chief Legal Officer 3